Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
May. 22 | UBS Starts Colruyt Coverage With Buy Rating | MT |
May. 22 | Colruyt: in the green on broker's comments | CF |
Sales 2024 * | 10.81B 11.73B 10.57B | Sales 2025 * | 11.49B 12.48B 11.24B | Capitalization | 6B 6.51B 5.86B |
---|---|---|---|---|---|
Net income 2024 * | 553M 600M 541M | Net income 2025 * | 349M 379M 341M | EV / Sales 2024 * | 0.58 x |
Net Debt 2024 * | 285M 309M 279M | Net Debt 2025 * | 338M 367M 331M | EV / Sales 2025 * | 0.55 x |
P/E ratio 2024 * |
6.53
x | P/E ratio 2025 * |
16.3
x | Employees | - |
Yield 2024 * |
4.76% | Yield 2025 * |
3.04% | Free-Float | 24.23% |
Managers | Title | Age | Since |
---|---|---|---|
Stefan Goethaert
CEO | Chief Executive Officer | - | 12-11-30 |
Stefaan Vandamme
DFI | Director of Finance/CFO | - | 19-01-31 |
Jef Colruyt
CHM | Chairman | - | 93-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rika Coppens
BRD | Director/Board Member | 52 | 19-03-30 |
Director/Board Member | 60 | 11-08-31 | |
Jef Colruyt
CHM | Chairman | - | 93-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.14% | 530B | |
-0.41% | 36.26B | |
+23.40% | 35.42B | |
+9.71% | 29.22B | |
+7.06% | 27.37B | |
-14.80% | 25.62B | |
+17.71% | 18.87B | |
+8.00% | 18.44B | |
+2.68% | 14.03B |
- Stock Market
- Equities
- COLR Stock
- COLR Stock